AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Gibson, CM Murphy, SA Rizzo, MJ Ryan, KA Marble, SJ McCabe, CH Cannon, CP Van de Werf, F Braunwald, E
Citation: Cm. Gibson et al., Is the corrected TIMI frame count an independent predictor of adverse outcome? Response, CIRCULATION, 102(2), 2000, pp. E19-E19

Authors: Lepor, NE Gross, SB Daley, WL Samuels, BA Rizzo, MJ Luko, SP Hickey, A Buchbinder, NA Naqvi, TZ
Citation: Ne. Lepor et al., Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease, AM J CARD, 86(1), 2000, pp. 107

Authors: Rizzo, MJ
Citation: Mj. Rizzo, Real time and relative indeterminacy in economic theory, AZIMUTH, 2, 2000, pp. 171-188

Authors: Becker, RC Hochman, JS Cannon, CP Spencer, FA Ball, SP Rizzo, MJ Antman, EM
Citation: Rc. Becker et al., Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists - Observations from the thrombolysis and thrombin inhibition in myocardial infarction 9 study, J AM COL C, 33(2), 1999, pp. 479-487

Authors: Gibson, CM Murphy, SA Rizzo, MJ Ryan, KA Marble, SJ McCabe, CH Cannon, CP Van de Werf, F Braunwald, E
Citation: Cm. Gibson et al., Relationship between TIMI frame count and clinical outcomes after thrombolytic administration, CIRCULATION, 99(15), 1999, pp. 1945-1950

Authors: Gibson, CM Ryan, KA Kelley, M Rizzo, MJ Mesley, R Murphy, S Swanson, J Marble, SJ Dodge, JT Giugliano, RP Cannon, CP Antman, EM
Citation: Cm. Gibson et al., Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results, AM HEART J, 137(6), 1999, pp. 1179-1184
Risultati: 1-6 |